Abstract
The first therapeutic use of glucocorticoids was in a patient with severe rheumatoid arthritis and the symptomatic benefit was astounding. Adverse effects from increasingly large doses led to them being overshadowed, dismissed as inappropriate treatment, and ignored for 20 years - but in the last 2 decades, the accumulating evidence and clinical practice suggest there is a justified renaissance in their use as a first-line treatment.
Original language | English |
---|---|
Journal | Clinical Pharmacology and Therapeutics |
DOIs | |
Publication status | Published - 7 Aug 2017 |
Keywords
- Journal Article